Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds – GenomeWeb
|
Gene Editing Startup Beam Therapeutics Launches With $87M in Series A Funds
GenomeWeb … Harvard for base editing technologies developed in the Liu Lab and patent filings by MGH for CRISPR technology developed in the Joung Lab, as well as an exclusive option for future sublicensing of additional Cas9 patent families and Cpf1 patent … |
